Thiotepa intrathecal injections for myelomatous central nervous system involvement-Reference-Cited by-同舟云学术

Thiotepa intrathecal injections for myelomatous central nervous system involvement

Published:2021-03-09 Issue:2 Volume:193 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Claudel Alexis¹^ORCID,Talbot Alexis¹^ORCID,Harel Stéphanie¹,Royer Bruno¹^ORCID,Naelle Lombion¹^ORCID,Zagdanski Anne‐Marie²^ORCID,Madelaine Isabelle³,Lemaire Pierre⁴,Arnulf Bertrand¹^ORCID

Affiliation:

1. Immuno‐Hematology Department Saint‐Louis Hospital (APHP)University of Paris Diderot‐Paris VII (Sorbonne Paris Cité) ParisFrance

2. Department of Radiology Saint‐Louis Hospital (AP‐HP)University of Paris Diderot‐Paris VII (Sorbonne Paris Cité) ParisFrance

3. Pharmacy Department Saint‐Louis Hospital (APHP)University of Paris Diderot‐Paris VII (Sorbonne Paris Cité) ParisFrance

4. Hematology Laboratory Saint‐Louis Hospital (APHP)University of Paris Diderot‐Paris VII (Sorbonne Paris Cité) Paris France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17343

Reference16 articles.

1. Global burden of multiple myeloma: A systematic analysis for the Global Burden of Disease study 2016.

2. Emergence of central nervous system myeloma in the era of novel agents

3. Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents

4. Patterns of Central Nervous System Involvement in Relapsed and Refractory Multiple Myeloma

5. Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies;Medical Oncology;2024-06-17

2. Case reports: Central nervous system involvement in patients with newly diagnosed multiple myeloma;Frontiers in Neurology;2023-02-02

3. Imaging findings in a case of leptomeningeal myelomatosis, a rare but critical central nervous system complication of multiple myeloma;The Neuroradiology Journal;2023-01-10

4. A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone;Case Reports in Hematology;2022-08-31

5. Profound response to venetoclax monotherapy in a patient with BCL-2 positive relapsed multiple myeloma and extramedullary CNS manifestations;Leukemia & Lymphoma;2022-07-06